您的位置: 首页 > 农业专利 > 详情页

USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS
专利权人:
The General Hospital Corporation;Dana-Farber Cancer Institute, Inc.
发明人:
David E. Fisher,Nisma Mujahid,Ryo Murakami,Nathanael S. Gray,Yanke Liang,Hwan Geun Choi
申请号:
US16489462
公开号:
US20200253981A1
申请日:
2018.02.28
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present disclosure provides methods of increasing skin pigmentation in a subject in need thereof using salt-inducible kinase (SIK) inhibitors, such as macrocyclic compounds of Formula (I), bicyclic urea compounds of Formula (II), (III), and (IV), and compounds of Formula (V), (VI), (VI-A), or (VII). Also provided are pharmaceutical compositions, methods, and uses that include or involve a compound described herein.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充